Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 376 shares at $52.81 ($20K) on 2018-06-06, disclosed to the SEC on 2018-06-07.
Open-market sale of $20k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |